JP2025505745A5 - - Google Patents
Info
- Publication number
- JP2025505745A5 JP2025505745A5 JP2024547667A JP2024547667A JP2025505745A5 JP 2025505745 A5 JP2025505745 A5 JP 2025505745A5 JP 2024547667 A JP2024547667 A JP 2024547667A JP 2024547667 A JP2024547667 A JP 2024547667A JP 2025505745 A5 JP2025505745 A5 JP 2025505745A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- deuterium
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263268020P | 2022-02-15 | 2022-02-15 | |
| US202263268024P | 2022-02-15 | 2022-02-15 | |
| US63/268,024 | 2022-02-15 | ||
| US63/268,020 | 2022-02-15 | ||
| PCT/EP2023/053752 WO2023156453A1 (en) | 2022-02-15 | 2023-02-15 | Phenethylamine derivatives, compositions, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505745A JP2025505745A (ja) | 2025-02-28 |
| JP2025505745A5 true JP2025505745A5 (enExample) | 2026-02-24 |
Family
ID=85278142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547667A Pending JP2025505745A (ja) | 2022-02-15 | 2023-02-15 | フェネチルアミン誘導体、組成物、及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250145566A1 (enExample) |
| EP (1) | EP4479372A1 (enExample) |
| JP (1) | JP2025505745A (enExample) |
| KR (1) | KR20240153567A (enExample) |
| AU (1) | AU2023222126A1 (enExample) |
| CA (1) | CA3244130A1 (enExample) |
| WO (1) | WO2023156453A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023539113A (ja) | 2020-08-18 | 2023-09-13 | サイビン アイアールエル リミテッド | フェネチルアミン誘導体、組成物およびその使用方法 |
| AU2022311812A1 (en) | 2021-07-14 | 2023-08-24 | Altrartis Therapeutics Inc. | Novel short-acting psychoactive compounds of the mdma class |
| CA3218730A1 (en) * | 2022-02-28 | 2023-08-31 | Denton W. Hoyer | Novel prodrug compounds of 3,4-methylenedioxymethamphetamine (mdma) and methods of synthesizing the same |
| EP4587423A1 (en) * | 2022-09-12 | 2025-07-23 | MiHKAL GmbH | Novel nootropic prodrugs of phenethylamine |
| WO2025228547A1 (en) * | 2024-05-01 | 2025-11-06 | Cybin Irl Limited | Processes for preparing phenethylamine compounds |
| WO2025240982A1 (en) * | 2024-05-17 | 2025-11-20 | 2A Biosciences, Inc. | 5-alkoxymethyl and 5-hydroxymethyl phenethylamines |
| CN120501709B (zh) * | 2025-06-03 | 2025-12-12 | 暨南大学 | 硫酸多黏菌素b干粉、吸入粉雾剂及其制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| US6488648B1 (en) | 1999-01-14 | 2002-12-03 | Teijin Limited | Device for feeding a powder in a predetermined amount and method thereof |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| NZ514442A (en) | 1999-03-03 | 2003-08-29 | Optinose As | Nasal delivery device |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| GB0019715D0 (en) | 2000-08-10 | 2000-09-27 | Pa Consulting Services | Device for delivering physiologically active agent in powdered form |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| AU2002340083A1 (en) | 2001-09-28 | 2003-04-07 | Kurve Technology, Inc | Nasal nebulizer |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| WO2008016677A2 (en) * | 2006-08-02 | 2008-02-07 | Auspex Pharmaceuticals, Inc. | Preparation and utility of deuterated amphetamines |
| CN112430187B (zh) * | 2019-08-07 | 2023-01-17 | 北京奇点势能科技有限公司 | 一种α,β-氘代胺类化合物、氘代药物及其制备方法 |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
-
2023
- 2023-02-15 AU AU2023222126A patent/AU2023222126A1/en active Pending
- 2023-02-15 EP EP23705530.6A patent/EP4479372A1/en active Pending
- 2023-02-15 CA CA3244130A patent/CA3244130A1/en active Pending
- 2023-02-15 JP JP2024547667A patent/JP2025505745A/ja active Pending
- 2023-02-15 US US18/730,423 patent/US20250145566A1/en active Pending
- 2023-02-15 KR KR1020247028843A patent/KR20240153567A/ko active Pending
- 2023-02-15 WO PCT/EP2023/053752 patent/WO2023156453A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540017A5 (enExample) | ||
| JP2023539113A5 (enExample) | ||
| JP2025506504A5 (enExample) | ||
| JP2021519267A5 (enExample) | ||
| JP2023526856A5 (enExample) | ||
| JP2023527575A5 (enExample) | ||
| JP2024522065A5 (enExample) | ||
| JP2024533291A5 (enExample) | ||
| JP2022545633A5 (enExample) | ||
| JP2021523200A5 (enExample) | ||
| JP2007508360A5 (enExample) | ||
| JP2009541209A5 (enExample) | ||
| JP2011529069A5 (enExample) | ||
| JP2012521994A5 (enExample) | ||
| JP2014520072A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| JP2011529054A5 (enExample) | ||
| JP2009531277A5 (enExample) | ||
| ES2759312T3 (es) | Compuestos de aminocarbonilcarbamato | |
| RU2005123802A (ru) | Производные адамантана, способы их получения и содержащие их фармацевтические композиции | |
| JP2022534704A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| AU2007251663B2 (en) | 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions | |
| JP2014518552A5 (enExample) |